New strategies for combination vaccines based on the extended recombinant bacterial ghost system

被引:70
|
作者
Eko, FO
Witte, A
Huter, V
Kuen, B
Fürst-Ladani, S
Haslberger, A
Katinger, A
Hensel, A
Szostak, MP
Resch, S
Mader, H
Raza, P
Brand, E
Marchart, J
Jechlinger, W
Haidinger, W
Lubitz, W
机构
[1] Univ Vienna, Inst Microbiol & Genet, A-1030 Vienna, Austria
[2] EVAX Technol, D-82152 Martinsried, Germany
关键词
bacterial ghost; combination vaccines; carrier system; targeting system; adjuvants;
D O I
10.1016/S0264-410X(98)00423-X
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Controlled expression of cloned PhiX174 gene E in Gram-negative bacteria results in lysis of the bacteria by formation of an E-specific transmembrane tunnel structure built through the cell envelope complex. Bacterial ghosts have been produced from a great variety of bacteria and are used as non-living candidate vaccines. In the recombinant ghost system, foreign proteins are attached on the inside of the inner membrane as fusions with specific anchor sequences. Ghosts have a sealed periplasmic space and the export of proteins into this space vastly extents the capacity of ghosts or recombinant ghosts to function as carriers of foreign antigens, immunomodulators or other substances. In addition, S-layer proteins forming shell-like self assembly structures can be expressed in bacterial candidate vaccine strains prior to E;mediated lysis. Such recombinant S-layer proteins carrying inserts of foreign epitopes of up to 600 amino acids within the flexible surface loop areas of the S-layer further extend the possibilities of ghosts as carriers of foreign epitopes. As ghosts do not need the addition of adjuvants to induce immunity in experimental animals they can also be used as carriers or targeting vehicles or as adjuvants in combination with subunit vaccines. Matrixes like dextran which can be used to fill the internal lumen of ghosts can be substituted with various ligands to bind the subunit or other materials of interest. Oral, aerogenic or parenteral immunization of experimental animals with recombinant ghosts induced specific humoral and cellular immune responses against bacterial and target components including protective mucosal immunity. The most relevant advantage of ghosts and recombinant bacterial ghosts as immunogens is that no inactivation procedures that denature relevant immunogenic determinants are employed in the production of ghosts. This fact explains the superior quality of ghosts when compared to other inactivated vaccines. As carriers of foreign antigens there is no limitation in the size of foreign antigens to be inserted and the capacity of all spaces including the membranes, periplasma and internal lumen of the ghosts can be fully utilized. Using the different building blocks and combining them into the recombinant ghost system represents a new strategy for adjuvant free combination vaccines. (C) 1999 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1643 / 1649
页数:7
相关论文
共 50 条
  • [1] Extended recombinant bacterial ghost system
    Lubitz, W
    Witte, A
    Eko, FO
    Kamal, M
    Jechlinger, W
    Brand, E
    Marchart, J
    Haidinger, W
    Huter, V
    Felnerova, D
    Stralis-Alves, N
    Lechleitner, S
    Melzer, H
    Szostak, MP
    Resch, S
    Mader, H
    Kuen, B
    Mayr, B
    Mayrhofer, P
    Geretschläger, R
    Haslberger, A
    Hensel, A
    JOURNAL OF BIOTECHNOLOGY, 1999, 73 (2-3) : 261 - 273
  • [2] Strategies of purification process development for bacterial recombinant vaccines.
    Yuan, T
    Yang, YP
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U207 - U207
  • [3] Recombinant vaccines and the development of new vaccine strategies
    Nascimento, I. P.
    Leite, L. C. C.
    BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH, 2012, 45 (12) : 1102 - 1111
  • [4] Strategies for the use of live recombinant avirulent bacterial vaccines for mucosal immunization
    Curtiss, R
    Doggett, T
    Nayak, A
    Srinivasan, J
    ESSENTIALS OF MUCOSAL IMMUNOLOGY, 1996, : 499 - 511
  • [6] Recombinant Plants Provide a New Approach to the Production of Bacterial Polysaccharide for Vaccines
    Smith, Claire M.
    Fry, Stephen C.
    Gough, Kevin C.
    Patel, Alexandra J. F.
    Glenn, Sarah
    Goldrick, Marie
    Roberts, Ian S.
    Whitelam, Garry C.
    Andrew, Peter W.
    PLOS ONE, 2014, 9 (02):
  • [7] Phototherapy-based combination strategies for bacterial infection treatment
    Wei, Guoqing
    Yang, Guang
    Wang, Yi
    Jiang, Hezhong
    Fu, Yiyong
    Yue, Guang
    Ju, Rong
    THERANOSTICS, 2020, 10 (26): : 12241 - 12262
  • [8] Vaccines administered simultaneously: directions for new combination vaccines based on an historical review of the literature
    Fletcher, MA
    Fabre, P
    Debois, H
    Saliou, P
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2004, 8 (06) : 328 - 338
  • [9] Pricing strategies for combination pediatric vaccines based on the lowest overall cost formulary
    Behzad, Banafsheh
    Jacobson, Sheldon H.
    Sewell, Edward C.
    EXPERT REVIEW OF VACCINES, 2012, 11 (10) : 1189 - 1197
  • [10] A new generation of vaccines based on whole cell recombinant Kluyveromyces lactis
    Breunig, Karin D.
    Arnold, Marina
    Krijger, Jorrit-Jan
    Schulze, Katja
    Behrens, Sven-Erik
    YEAST, 2013, 30 : 82 - 82